Lupin makes impairment provision for GavisLupin took a hit worth Rs 1,464.35 crore on US-based Gavis, which it acquired in 2015 for $880 million (Rs 5,610 crore then).
15 May, 2018, 11.29 PM IST
IIFL’s Bhavesh Gandhi prefers mid-cap to frontline pharma: Here’s why"For Lupin, migrating the portfolio from a regular oral solids to specialties would take time."
15 May, 2018, 05.28 PM IST
Lupin reports Rs 777 crore Q4 loss on one-time impairment provisionsThe company had reported Rs 707 crore profit for the year-ago quarter.
15 May, 2018, 03.51 PM IST
Lupin net skids, says Gavis deal ‘shy’ of expectationsThe business fell 13.2% to Rs 1,900.7 crore from a year earlier and contributed 46% of sales.
25 May, 2017, 11.58 AM IST
GAVIS Pharma LLC looking to exit Bengaluru-based Wintac LtdGavis Pharma LLC is now exploring options to exit its listed Indian arm. Wintac Ltd was not part of the 2015 deal struck between Lupin & Ga...
08 Aug, 2016, 03.55 PM IST
Indian pharma takes M&A route to build a global footprintLast week Dr. Reddy's acquired a portfolio of eight complex generics in the US from Teva in a deal worth $350 million.
13 Jun, 2016, 05.43 AM IST
Lupin launches generic insomnia drug in USDrug major Lupin has launched a generic insomnia drug, Zolpidem Sublingual tablets, in the US market with 180-days of marketing exclusivity.
05 Apr, 2016, 02.34 PM IST
Lupin completes acquisition of GAVIS PharmaThe acquisition enhances the company's scale in the US generic market and also broadens its pipeline in dermatology and controlled substanc...
09 Mar, 2016, 01.52 PM IST
Lupin, Gavis to sell 2 drugs to fulfil US FTC conditionThe acquisition creates the fifth largest portfolio of abbreviated new drug application (ANDA) filings with the USFDA, addressing a USD 63....
21 Feb, 2016, 12.32 PM IST
It may take another quarter for Lupin to post a robust showMumbaibased pharma company Lupin has posted better-than-expected numbers after reporting dismal figures for four successive quarters.
09 Feb, 2016, 06.40 AM IST
InvaGen, Exelan acquisition will give Cipla manufacturing plant, R&D base in USCipla on Friday fulfilled a longstanding desire to expand its beachhead in the US by buying Hetero Pharma’s US business for about $550 mill...
05 Sep, 2015, 06.34 AM IST
Buyouts unlikely to harm debt-free Lupin's healthWith no new blockbuster drugs going off patent in the near term, generic pharma companies have to explore new areas of growth like specialt...
27 Jul, 2015, 11.09 AM IST
Lupin buys US generics firm Gavis for Rs 5606 croreThe deal, which is cash-free and debt-free, widens the company's pipeline in dermatology and controlled substance products, Lupin said.
24 Jul, 2015, 03.52 AM IST
Lupin acquires US-based Gavis Pharma for 5,600 crore; Q1 PAT down 16%, stock slumpsShares of pharmaceuticals major Lupin plunged about 6% in intraday on Thursday as the company disappointed with its Q1 results.
23 Jul, 2015, 05.19 PM IST
Controversial vaccine studies: Why is Bill & Melinda Gates Foundation under fire from critics in India?Bill & Melinda Gates Foundation has funded two entities that have played a key role in the immunization programme and are both under fire f...
31 Aug, 2014, 03.47 PM IST
Bill & Melinda Gates Foundation: GAVI & PHFI help create incentives for pharma cos to make low-cost vaccinesThe project used vaccines that are licensed in India and that have been administered safely around the world tens of millions of times, pre...
31 Aug, 2014, 04.30 AM IST
Foreign Investment Promotion Board clears 14 FDI proposals worth Rs 1,528 croreThe proposals of Agilent Technologies, Christine ComarmondMargotin, HLG Enterprises, Gstaad Hotels and three others have been rejected.
06 Aug, 2014, 03.35 PM IST